GSK3β has complex and multitargeted biological effects, including regulation of multiple pathways involved in insulin resistance, oxidative stress, autophagy, and apoptosis, in DN-related podocyte injury [17–19]. The gene discussed is INS; the disease is liver dysplastic nodule.